Applied Biosystems transfers interest in Celera Diagnostics to Celera Genomics.

Applied Biosystems has transferred its 50% interest in Celera Diagnostics to Celera Genomics in exchange for various considerations and cash. As part of the deal, Applied Biosystems will serve the end-user clinical diagnostics instrumentation market as well as research markets.

Applied Biosystems has announced the transfer of its 50% interest in Celera Diagnostics to Celera Genomics. The transaction, finalized on May 24, 2025, includes various considerations and cash payments. As part of the agreement, Applied Biosystems will continue to serve the end-user clinical diagnostics instrumentation market and research markets.

The move comes as Celera Diagnostics, previously known as Celera Genomics, expands its diagnostics portfolio. Applied Biosystems, a leading provider of life science tools and services, will retain its position in the market while Celera Genomics gains access to additional resources and expertise.

The deal reflects the growing importance of clinical diagnostics and the need for innovative solutions in the sector. By combining forces, the two companies aim to enhance their offerings and better serve their respective markets.

For investors, this transaction signifies a strategic shift in the diagnostics landscape. Applied Biosystems' focus on research and clinical diagnostics instrumentation will remain unchanged, while Celera Genomics benefits from the expanded capabilities and market reach.

The transfer of interest is a significant development in the life sciences industry, highlighting the importance of strategic partnerships and acquisitions in driving innovation and growth.

References:
[1] https://www.selectscience.net/article/thermo-fisher-scientific-introduces-fast-automated-plasmid-dna-purification-kit
[2] https://www.morningstar.com/news/business-wire/20250519067489/apreo-health-announces-presentation-of-clinical-data-from-the-breathe-12-trials-at-ats-2025-and-publication-of-six-month-data-in-american-journal-of-respiratory-and-critical-care-medicine